Metoprolol-Associated Central Nervous System Complications
- PMID: 32582495
- PMCID: PMC7306637
- DOI: 10.7759/cureus.8236
Metoprolol-Associated Central Nervous System Complications
Abstract
Metoprolol is a common medication used by the elderly because it is affordable and has proven to decrease mortality in cardiovascular disease. Multiple studies have reported central nervous system (CNS) side effects associated with use of beta-blockers. The risk of beta-blocker CNS side effects is directly associated with the lipophilic property of the drug. We present the case of an 84-year-old male presented to the clinic complaining of increased confusion, fatigue, lightheadedness, nightmares, sleep disturbance, and gait problems for four weeks. The patient was evaluated for neurogenic and cardiogenic causes of his symptoms and both were ruled out. We believe that further review of his medical chart and medication reconciliation will lead us to the underlying cause of his symptoms. Despite being an effective treatment option, there are risks associated with beta-blocker therapy. The most common symptoms are psychiatric conditions, bizarre and vivid dreams, sleep disturbances, delirium, psychosis, and visual hallucinations. Elderly patients who are started on beta-blockers require close monitoring for any adverse neurological symptoms.
Keywords: beta-blocker side effects; bizzare and vivid dreams; cns side effects; delirium; metoprolol side effects; metoprolol therapy; metoprolol toxicity; sleep disturbances.
Copyright © 2020, Shah et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
CNS-related side-effects with metoprolol and atenolol.Eur J Clin Pharmacol. 1985;28 Suppl:69-72. doi: 10.1007/BF00543713. Eur J Clin Pharmacol. 1985. PMID: 4054193 Clinical Trial.
-
[Hallucinations and vivid dreams by use of metoprolol].Tijdschr Psychiatr. 2010;52(2):117-21. Tijdschr Psychiatr. 2010. PMID: 20146183 Dutch.
-
Acute delirium induced by metoprolol.Cardiovasc Drugs Ther. 2002 Mar;16(2):161-5. doi: 10.1023/a:1015761618314. Cardiovasc Drugs Ther. 2002. PMID: 12090909
-
Beta-blockers and central nervous system side effects.Pharmacol Ther. 1990;46(2):163-97. doi: 10.1016/0163-7258(90)90092-g. Pharmacol Ther. 1990. PMID: 1969642 Review.
-
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.Eur J Clin Pharmacol. 1985;28 Suppl:55-63. doi: 10.1007/BF00543711. Eur J Clin Pharmacol. 1985. PMID: 2865151 Review.
Cited by
-
Development of QSAR models to predict blood-brain barrier permeability.Front Pharmacol. 2022 Oct 20;13:1040838. doi: 10.3389/fphar.2022.1040838. eCollection 2022. Front Pharmacol. 2022. PMID: 36339562 Free PMC article.
-
The Role of Beta-Adrenergic Receptors in Depression and Resilience.Biomedicines. 2022 Sep 23;10(10):2378. doi: 10.3390/biomedicines10102378. Biomedicines. 2022. PMID: 36289638 Free PMC article. Review.
-
Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments.Curr Pain Headache Rep. 2022 Jul;26(7):493-504. doi: 10.1007/s11916-022-01051-9. Epub 2022 May 19. Curr Pain Headache Rep. 2022. PMID: 35587859 Review.
-
Neuropsychiatric Consequences of Lipophilic Beta-Blockers.Medicina (Kaunas). 2021 Feb 9;57(2):155. doi: 10.3390/medicina57020155. Medicina (Kaunas). 2021. PMID: 33572109 Free PMC article. Review.
References
-
- Beta-blockers and central nervous system side effects. McAinsh J, Cruickshank JM. Pharmacol Ther. 1990;46:163–197. - PubMed
-
- CNS-related side-effects with metoprolol and atenolol. Cove-Smith JR, Kirk CA. Eur Clin Pharmacol. 1985;28:69–72. - PubMed
-
- Familial liability for metoprolol-induced psychosis. Rietveld L, van der Hoek T, van Beek MHCT, Schellekens AFA. Gen Hosp Psych. 2015;37:620. - PubMed
Publication types
LinkOut - more resources
Full Text Sources